nav[aria-label="Primary Navigation"] { padding: 0; & ul { list-style: none; width: 100%; display: flex; flex-direction: row; justify-content: start; align-items: start; gap: 30px; padding: 0; & li { margin: 0; } & ul li { list-style: none; } } }

Active Topics

See what others are discussing and join the conversation.

Active Topics

See what others are discussing and join the conversation.

Join a current conversation

Enhertu for HER2-Low and -Ultralow Metastatic Breast Cancer
Enhertu for HER2-Low and -Ultralow Metastatic Breast Cancer Dec 12, 2024 Dr. Aditya Bardia discusses Enhertu for metastatic hormone receptor-positive, HER2-low and -ultralow breast cancer and explains those terms. At the 2024 San Antonio Breast Cancer Symposium, Dr. Aditya Bardia, director of the Breast Oncology Program…

Welcome!

It looks like you're new here. Sign in or register to get started.

Unanswered posts

These posts are awaiting responses - can you help?

Check them out

Quick Links

Community Compass

The Breastcancer.org Blog

When Time Becomes an Accommodation
Our Community Director reflects on conversations with members of our young with MBC support group about giving themselves time and grace.
How to Respond to Good Intentions That Fall Flat
Community Director Melissa Jenkins offers advice for responding to the gap between well-meant intentions and their negative impact.
When It Feels Like Your Body Is Betraying You
Community Director Melissa Jenkins offers perspective on learning to trust your body again after a breast cancer diagnosis.

View Community Compass

Support Breastcancer.org

Browse our merchandise

Shop now

Have feedback about the Community?

We'd love to hear it.

Share with us